1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Specialties
Aamaxan Transport Group, Inc.

Aamaxan Transport Group, Inc.

AAXT
Aamaxan Transport Group, Inc.US flagOther OTC
0.00
USD
-NaN
- -
1,599.00Market Cap
2006 Y
2007 Y
2008 Y
TTM
Revenue per Share
- -
- -
- -
1.57
Basic EPS, GAAP
-0.32
-0.13
- -
0.33
Free Cash Flow per Basic Share
-0.04
-0.13
- -
- -
Dividend per Share
- -
- -
- -
0.19
Book Value per Share
-43.09
-30.37
- -
1
Tangible Book Value per Share
-0.07
-0.17
- -
0.92
Basic Weighted Avg Shares
- -
- -
- -
10
Sales/Revenue/Turnover
- -
- -
- -
16
Operating Margin (%)
- -
- -
- -
32.23
Depreciation Expense
- -
- -
- -
- -
Net Income, GAAP
- -
- -
- -
3
Effective Tax Rate (%)
- -
- -
- -
33.77
Profit Margin (%)
- -
- -
- -
21.31
Working Capital
- -
- -
4
4
LT Debt
- -
- -
- -
- -
Total Equity
- -
- -
14
14
Return on Invested Capital (%)
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
67.27

Capital Structure

FRC

•

in mil. unless spec.
Jul'08
Oct'08
Jan'08
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
15
15
15
Market Capitalization
- -
- -
- -

Working Capital

FRC

•

in mil. unless spec.
Jul'08
Oct'08
Jan'08
Total Current Assets
- -
- -
9
Cash, Cash Equivalents & STI
- -
- -
2
Accounts Receivable, Net
- -
- -
2
Inventories
- -
- -
1
Total Current Liabilities
- -
- -
5
Payables & Accruals
- -
- -
3
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-33,954.18%
Free Cash Flow
- -
- -
-27.79%
Net Income, GAAP
- -
- -
3.24%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2007
- -
- -
- -
- -
- -
2008
8
8
- -
- -
- -
2009
10
10
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2007
-0.05
-0.01
-0.03
- -
-0.13
2008
0.12
0.11
-0.05
- -
- -
2009
0.13
0.11
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2007
- -
- -
- -
- -
- -
2008
0.04
0.09
- -
- -
- -
2009
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Chen Zhong
Full Time Employees
70
Sector
Healthcare
Industry
Medical - Specialties
Address
1440 Hongqiao Road United States of America
IPO Date
Jul 31, 2023
Website
aamaxan.com
Similar Companies
IVIM Technology (460470.KQ)
Rion Co., Ltd. (6823.T)
Gencurix, Inc. (229000.KQ)
Avitar, Inc. (AVTI)
QuidelOrtho Corporation (0A55.L)
ChromoCure, Inc. (KKUR)
Business
Aamaxan Transport Group, Inc. (AAXT) operates as a holding company primarily engaged in the distribution and sale of hemodialysis equipment and related medical products used during dialysis therapy through its subsidiaries; its core offerings include hemodialysis disposables such as dialyzers and bloodlines, as well as equipment like HDE systems mainly supplied to hospitals and dialysis centers in China. The company, originally founded as Shanghai Medical Technology Co., Ltd. and renamed Aamaxan Transport Group, Inc. in April 2008 following a share exchange transaction, maintains its principal operations from Suite 6B, 1440 Hongqiao Road, Changning District, Shanghai, China, with a registered office in Dover, Delaware, and focuses on the medical technology segment targeting healthcare providers in the Asia-Pacific region. Despite its transportation sector classification on some exchanges, recent profiles confirm its medical device business model with no reported acquisitions, funding rounds, partnerships, new product launches, or strategic expansions within the last 1-2 years; the company remains a development-stage entity with limited disclosures and faced a U.S. SEC trading suspension in 2021 over informational concerns.